NANJING, China, Jan. 4, 2024 /PRNewswire/ — On January 10, 2024, the GenScript Biotech Global Forum is set to inaugurate with grandeur during the 42nd J.P. Morgan Healthcare Conference in San Francisco, USA. The forum, themed “Innovations and Breakthroughs Shaping Tomorrow’s Cell and Gene Therapies,” will take off from a fresh, multi-dimensional perspective, gathering leading figures… Continue reading GenScript Biotech Global Forum 2024 to Commence, Infusing New Vitality into the GCT Industry
Tag: Morgan
Dynavax to Present at the 42nd Annual J.P. Morgan Healthcare Conference
EMERYVILLE, Calif., Jan. 3, 2024 /PRNewswire/ — Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, today announced that the Company will present at the 42nd Annual J.P. Morgan Healthcare Conference on Thursday, January 11 at 11:15 a.m. PT. The presentation will be webcast and may be accessed through the “Events… Continue reading Dynavax to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Select Medical Holdings Corporation Announces Potential Separation of Concentra
MECHANICSBURG, Penn., Jan. 3, 2024 /PRNewswire/ — Select Medical Holdings Corporation (“Select Medical,” “we,” “us,” or “our”) (NYSE: SEM) today announced that its board of directors has approved a plan to pursue the separation of Select Medical’s wholly-owned occupational health services business, Concentra Group Holdings Parent, LLC (“Concentra” and such business, the “Concentra business”). If… Continue reading Select Medical Holdings Corporation Announces Potential Separation of Concentra
BELOVED AFFIRM ORIGINALS SERIES “GOING HOME” RETURNS TO GREAT AMERICAN PURE FLIX FOR SECOND COMPELLING SEASON, CELEBRATING THE JOURNEY OF LIFE
Going Home premiered on Great American Pure Flix in June of 2022 with the show’s first season and quickly became a member favorite. Creator Dan Merchant returns as the AFFIRM Originals series’ showrunner and lead director. Cynthia Geary once again stars as Charley Copeland, a hospice nurse who sees her role as a calling from God… Continue reading BELOVED AFFIRM ORIGINALS SERIES “GOING HOME” RETURNS TO GREAT AMERICAN PURE FLIX FOR SECOND COMPELLING SEASON, CELEBRATING THE JOURNEY OF LIFE
HARMONY BIOSCIENCES TO PRESENT AT THE 42ND ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
PLYMOUTH MEETING, Pa., Jan. 3, 2024 /PRNewswire/ — Harmony Biosciences Holdings, Inc. (“Harmony” or the “Company”) (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients with rare neurological diseases, today announced its participation in the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco, CA. Jeffrey M. Dayno, M.D., President… Continue reading HARMONY BIOSCIENCES TO PRESENT AT THE 42ND ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
Rigel to Present at the 42nd Annual J.P. Morgan Healthcare Conference
SOUTH SAN FRANCISCO, Calif., Jan. 3, 2024 /PRNewswire/ — Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that Raul Rodriguez, the company’s president and CEO, will present a company overview at the 42nd Annual J.P. Morgan Healthcare Conference on Thursday, January 11, 2024 at 12:00 p.m. PT in San Francisco, CA. To access the live webcast… Continue reading Rigel to Present at the 42nd Annual J.P. Morgan Healthcare Conference
South Rampart Pharma to Present at Biotech Showcase 2024
Hernan Bazan, MD, FACS, CEO and Co-Founder, will provide a company update on SRP-001, the first-in-class non-opioid analgesic with FDA Fast Track designation during JP Morgan Healthcare week NEW ORLEANS, Jan. 3, 2024 /PRNewswire/ — South Rampart Pharma, Inc. (“South Rampart” or the “Company”), a clinical-stage life science company pioneering innovative pain treatments, announced today that… Continue reading South Rampart Pharma to Present at Biotech Showcase 2024
AllianceBernstein obtains China mutual fund business licence
U.S.-based AllianceBernstein Holding LP has obtained a license to run its wholly-owned mutual fund business in China, the company said on Tuesday, making it the latest foreign asset manager to tap China’s $3.8 trillion mutual fund market. “AllianceBernstein will offer Chinese investors onshore investment products and solutions, and help them explore opportunities in China’s domestic… Continue reading AllianceBernstein obtains China mutual fund business licence
Danaher to Present at J.P. Morgan Healthcare Conference
WASHINGTON, Jan. 2, 2024 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the J.P. Morgan Healthcare Conference in San Francisco, California on Tuesday, January 9, 2024 at 2:15 p.m. ET. The event will be simultaneously webcast on www.danaher.com. ABOUT DANAHERDanaher is a leading… Continue reading Danaher to Present at J.P. Morgan Healthcare Conference
Syndax Announces Presentation at 42nd Annual J.P. Morgan Healthcare Conference
WALTHAM, Mass., Jan. 2, 2024 /PRNewswire/ — Syndax Pharmaceuticals (Nasdaq: SNDX), a clinical-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that Michael A. Metzger, Chief Executive Officer of Syndax, will present at the 42nd Annual J.P. Morgan Healthcare Conference on Monday, January 8, 2024 at 5:15 p.m. PT/ 8:15 p.m. ET.… Continue reading Syndax Announces Presentation at 42nd Annual J.P. Morgan Healthcare Conference